Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Drug combo for breast cancer in post-menopausal women shows promise

Drug combo for breast cancer in post-menopausal women shows promise

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal women

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal women

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

Amgen's Prolia receives FDA approval for new indications to treat cancer patients

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

New data from Pfizer's investigational oncology compounds to be presented at EMCC 2011

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

SWOG selects four cancer researchers for 2011 Young Investigator Training Course

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Amgen to present data from several Prolia studies at ASBMR 2011 meeting

Syndax receives European patent allowance for entinostat to treat metastatic breast cancer

Syndax receives European patent allowance for entinostat to treat metastatic breast cancer

High-dose vitamin D reduces musculoskeletal pain in breast cancer patients

High-dose vitamin D reduces musculoskeletal pain in breast cancer patients

APP to commence marketing Letrozole Tablets for breast cancer in the U.S.

APP to commence marketing Letrozole Tablets for breast cancer in the U.S.

NCIC CTG's exemestane clinical trial data on breast cancer presented at ASCO 2011

NCIC CTG's exemestane clinical trial data on breast cancer presented at ASCO 2011

Exemestane reduces risk of breast cancer in high-risk, postmenopausal women

Exemestane reduces risk of breast cancer in high-risk, postmenopausal women

Researcher to evaluate new approach for treatment of triple-negative breast cancer

Researcher to evaluate new approach for treatment of triple-negative breast cancer

Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients

Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis

NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer

NCI sponsors multi-center phase 2 study of entinostat-anastrozole combination in triple negative breast cancer

Syndax reports promising results from entinostat preclinical studies in breast cancer

Syndax reports promising results from entinostat preclinical studies in breast cancer

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Higher co-payments lead to early discontinuation of life-saving therapy for breast cancer

Higher co-payments lead to early discontinuation of life-saving therapy for breast cancer

Simple fingertip test may help evaluate risk for CTS in breast cancer patients

Simple fingertip test may help evaluate risk for CTS in breast cancer patients

Depression drug appears effective in reducing pain associated with breast cancer treatment

Depression drug appears effective in reducing pain associated with breast cancer treatment